Skin Infections in Immunocompromised Children

  • Maria Teresa García-Romero
Chapter

Abstract

Infections in immunocompromised children pose a challenge to dermatologists, both because the clinical presentation of common infectious diseases can be greatly modified making diagnosis difficult and because some of these infections have the potential to disseminate and have severe consequences, sometimes fatal. In many cases the skin is the easiest and most accessible way to make a correct diagnosis and initiate adequate treatment. This chapter describes some of the most important bacterial, fungal, viral, mycobacterial, and parasitic infections that children with altered immune systems present.

Keywords

Immunodeficiency Immunocompromised Infections Opportunistic infections 

References

  1. 1.
    López FA, Sanders CV. Recognizing cutaneous signs of infection in immunocompromised patients. Abstr Hematol Oncol. 2003;6(3):19–26.Google Scholar
  2. 2.
    Lopez FA, Sanders CV. Dermatologic infections in the immunocompromised (non-HIV) host. Infect Dis Clin N Am. 2001;15(2):671–702. xi.CrossRefGoogle Scholar
  3. 3.
    Fink M, Conrad D, Mark M, Browning JC. Primary ecthyma gangrenosum as a presenting sign of leukemia in a child. Dermatol Online J. 2012;18(3):3.PubMedGoogle Scholar
  4. 4.
    Fergie JE, Shema SJ, Lott L, Crawford R, Patrick C. Pseudomonas aeruginosa bacteremia in immunocompromised children: analysis of factors associated with poor outcome. Clin Infect Dis. 1994;18(3):4.CrossRefGoogle Scholar
  5. 5.
    Fallah S, Tabatabaei A, Pournasir Z, Chavoshzadeh Z, Rezaei N. Cutaneous cytomegalovirus infection in a child with hyper IgE and specific defects in antibody response to protein vaccines. Braz J Infect Dis. 2011;15(5):484–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Shrestha S, Wang C, Aissani B, Wilson CM, Tang J, Kaslow RA. Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents. Cancer Epidemiol Biomarkers Prev. 2007;16(8):1626–32.CrossRefPubMedGoogle Scholar
  7. 7.
    Euvrard S, Kanitakis J, Cochat P, Cambazard F, Claudy A. Skin diseases in children with organ transplants. J Am Acad Dermatol. 2001;44(6):932–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Cowan KR, Gonzalez Santiago TM, Tollefson MM. Acquired epidermodysplasia verruciformis in a child with the human immunodeficiency virus. Pediatr Dermatol. 2013;30(6):e252–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Lowe SM, Katsidzira L, Meys R, Sterling JC, de Koning M, Quint W, et al. Acquired epidermodysplasia verruciformis due to multiple and unusual HPV infection among vertically-infected, HIV-positive adolescents in Zimbabwe. Clin Infect Dis. 2012;54(10):e119–23.CrossRefPubMedCentralPubMedGoogle Scholar
  10. 10.
    Sandoval M, Ortiz M, Diaz C, Majerson D, Molgo M. Cutaneous manifestations in renal transplant recipients of Santiago, Chile. Transplant Proc. 2009;41(9):3752–4.CrossRefPubMedGoogle Scholar
  11. 11.
    Huang W, Morrell D. Successful treatment of recalcitrant warts with topical squaric acid in immunosuppressed child. Pediatr Dermatol. 2008;25(2):275–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Gupta M, Bayliss SJ, Berk DR. Topical cidofovir for refractory verrucae in children. Pediatr Dermatol. 2013;30(1):131–4.CrossRefPubMedGoogle Scholar
  13. 13.
    Field S, Irvine AD, Kirby B. The treatment of viral warts with topical cidofovir 1%: our experience of seven paediatric patients. Br J Dermatol. 2009;160(1):223–4.CrossRefPubMedGoogle Scholar
  14. 14.
    Ozyurek E, Senturk N, Kefeli M, Gungor O, Akbalik M, Aydin F, et al. Ulcerating molluscum contagiosum in a boy with relapsed acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2011;33(3):e114–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Toro JR, Wood LV, Patel NK, Turner ML. Topical cidofovir. A novel treatment for recalcitrant molluscum contagiosum in children infected with Human Immunodeficiency Virus 1. Arch Dermatol. 2000;136:983–5.PubMedGoogle Scholar
  16. 16.
    Guerin M, Lepecheur V, Rachieru-Sourisseau P, Reguerre Y, Pellier I, Martin L. Usefulness of topical cidofovir treatment for recalcitrant molluscum contagiosum in immunocompromised children. Arch Pediatr. 2012;19(11):1157–63.CrossRefPubMedGoogle Scholar
  17. 17.
    Stout JE, Saharia KK, Nageswaran S, Ahmed A, Dukes HC. Racial and ethnic disparities in pediatric tuberculosis in North Carolina. Arch Pediatr Adolesc Med. 2006;160:631–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Young J, O’Connor ME. Risk factors associated with latent tuberculosis infection in Mexican American children. Pediatrics. 2005;115(6):e647–53.CrossRefPubMedGoogle Scholar
  19. 19.
    Miranda AE, Dietze R, Maciel EL, Prado TN, Caus AL, Silva MM, et al. Tuberculosis and AIDS co-morbidity in children: linkage of databases from Espirito Santo State, Brazil. J Trop Pediatr. 2011;57(4):296–8.CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Davies MA, Connell T, Johannisen C, Wood K, Pienaar S, Wilkinson KA, et al. Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay. AIDS. 2009;23(8):961–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Sethuraman G, Ramesh V. Cutaneous tuberculosis in children. Pediatr Dermatol. 2013;30(1):7–16.CrossRefPubMedGoogle Scholar
  22. 22.
    Handog EB, Gabriel TG, Pineda RT. Management of cutaneous tuberculosis. Dermatol Ther. 2008;21(3):154–61.CrossRefPubMedGoogle Scholar
  23. 23.
    Gantzer A, Neven B, Picard C, Brousse N, Lortholary O, Fischer A, et al. Severe cutaneous bacillus Calmette-Guerin infection in immunocompromised children: the relevance of skin biopsy. J Cutan Pathol. 2013;40(1):30–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Edeer Karaca N, Boisson-Dupuis S, Aksu G, Bustamante J, Kandiloglu G, Ozsan N, et al. Granulomatous skin lesions, severe scrotal and lower limb edema due to mycobacterial infections in a child with complete IFN-gamma receptor-1 deficiency. Immunotherapy. 2012;4(11):1121–7.CrossRefPubMedGoogle Scholar
  25. 25.
    García-Romero MT, Arenas R. Cutaneous infections by Mycobacterium marinum: review of the literature. DCMQ. 2008;6(4):262–7.Google Scholar
  26. 26.
    García-Romero MT, López-Aguilar E, Arenas R. Onychomycosis in immunosuppressed children receiving chemotherapy. Pediatr Dermatol. 2012;31(5):618–20.CrossRefPubMedGoogle Scholar
  27. 27.
    Gaitan-Cepeda LA, Sanchez-Vargas LO, Pavia-Ruz N, Munoz-Hernandez R, Villegas-Ham J, Caballos-Salobrena A. Oral Candida in Mexican children with malnutrition, social marginalization, or HIV/AIDS. Pan Am J Public Health. 2012;31(1):48–53.CrossRefGoogle Scholar
  28. 28.
    Bruce Diemond J, Lopez C, Huerta Romano F, Montiel Castillo C. Fungal (Candida) infections in the immunocompromised pediatric patient. Drugs Today. 2008;44 Suppl 4:45–51.PubMedGoogle Scholar
  29. 29.
    Marcoux D, Jafarian F, Joncas V, Buteau C, Kokta V, Moghrabi A. Deep cutaneous fungal infections in immunocompromised children. J Am Acad Dermatol. 2009;61(5):857–64.CrossRefPubMedGoogle Scholar
  30. 30.
    Torrelo A, Hernandez-Martin A, Scaglione C, Madero L, Colmenero I, Zambrano A. Aspergilosis cutánea primaria en un niño con leucemia. Actas Dermosifiliogr. 2007;98:276–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Naeem F, Rubnitz JE, Hakim H. Isolated nasal septum necrosis caused by Aspergillus flavus in an immunocompromised child. Pediatr Infect Dis J. 2011;30(7):627–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Idris N, Lim LH. Nasal eschar: a warning sign of potentially fatal invasive fungal sinusitis in immunocompromised children. J Pediatr Hematol Oncol. 2012;34(4):e134–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis. 2002;35:12.Google Scholar
  34. 34.
    Cooke NS, Feighery C, Armstrong DK, Walsh M, Dempsey S. Cutaneous Fusarium solani infection in childhood acute lymphoblastic leukaemia. Clin Exp Dermatol. 2009;34(5):e117–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Mellouli F, Ksouri H, Barbouche R, Maamer M, Hamed LB, Hmida S, et al. Successful treatment of Fusarium solani ecthyma gangrenosum in a patient affected by leukocyte adhesion deficiency type 1 with granulocytes transfusions. BMC Dermatol. 2010;10:10.CrossRefPubMedCentralPubMedGoogle Scholar
  36. 36.
    Cantatore-Francis JL, Shin HT, Heilman E, Glick SA. Primary Cutaneous Zygomycosis in two immunocompromised children. Pediatr Dermatol. 2007;24(3):6.CrossRefGoogle Scholar
  37. 37.
    García-Romero MT, García-Méndez J, Arenas R, Ferrari-Carballo T, Chanona-Vilchis J, Cervera-Ceballos E. Zygomycosis in two hematologic cases. Case Rep Infect Dis. 2011;2011:181782.PubMedCentralPubMedGoogle Scholar
  38. 38.
    Hussain S. A 15-year old Hispanic girl with “bump”. Infect Dis Child. 2008.Google Scholar
  39. 39.
    Patel A, Hogan P, Walder B. Crusted scabies in two immunocompromised children: successful treatment with oral ivermectin. Australas J Dermatol. 1999;40(1):37–40.CrossRefPubMedGoogle Scholar
  40. 40.
    Chosidow O. Scabies and pediculosis. Lancet. 2000;355(9206):819–26.CrossRefPubMedGoogle Scholar
  41. 41.
    Ivy SP, Mackall CL, Gore L, Gress RE, Hartley AH. Demodicidosis in childhood acute lymphoblastic leukemia; an opportunistic infection occurring with immunosuppression. J Pediatr. 1995;127(5):751–4.CrossRefPubMedGoogle Scholar
  42. 42.
    Sahn EE, Sheridan DM. Demodicidosis in a child with leukemia. J Am Acad Dermatol. 1992;27(5 Pt 2):799–801.CrossRefPubMedGoogle Scholar
  43. 43.
    Castanet J, Monpoux F, Mariani R, Ortonne JP, Lacour JP. Demodicidosis in an immunodeficient child. Pediatr Dermatol. 1997;14(3):219–20.CrossRefPubMedGoogle Scholar
  44. 44.
    Damian D, Rogers M. Demodex infestation in a child with leukaemia: treatment with ivermectin and permethrin. Int J Dermatol. 2003;42(9):724–6.CrossRefPubMedGoogle Scholar
  45. 45.
    Moore RF, Schaetzen V, Joseph M, Lee IA, Miller-Monthrope Y, Phelphs R, et al. Acquired Epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterization. Arch Dermatol. 2012;148(1):128–30.CrossRefPubMedGoogle Scholar
  46. 46.
    Hansford JR, Cole C, Blyth CC, Gottardo NG. Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy. J Antimicrob Chemother. 2012;67(7):1807–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Maria Teresa García-Romero
    • 1
  1. 1.National Institute of Pediatrics, Department of DermatologyMéxicoUSA

Personalised recommendations